Objective: To establish a three-step purification method of preparative-scale antiCD20 (Fab')2 using AKTA prime.
Methods: AntiCD20 (Fab')2 was extracted by hyperosmotic solution and then purified by CM sepharose FF, phenyl sepharose FF, and protein G sepharose FF.
Results: Around 8 mg anti-CD20 (Fab')2, whose purification was 96.678%, was purified. The antigen-binding activity of antiCD20 (Fab')2 was similar to that of antiCD20 (Fab')2 purified by protein G sepharose FF and S-100.
Conclusion: The three-step purification method can obtain high-purity preparative-scale antiCD20 (Fab')2 in a simple way.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
A potential mechanism of rituximab-induced inhibition of tumor growth through its sensitization to tumor necrosis factor-related apoptosis-inducing ligand-expressing host cytotoxic cells.
Leuk Lymphoma
January 2011
Department of Microbiology, Jonnson Comprehensive Cancer Center at UCLA, Los Angeles, CA, USA.
Rituximab (anti-CD20 mAb) mediates antibody-dependent cell-mediated cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), and apoptosis in B-NHL cells. The contribution of other host-mediated cytotoxic effects has not been examined. The expression of death-inducing ligands (e.
View Article and Find Full Text PDFRituximab-mediated cell signaling and chemo/immuno-sensitization of drug-resistant B-NHL is independent of its Fc functions.
Clin Cancer Res
November 2009
Department of Microbiology, Immunology, and Molecular Genetics, Jonsson Comprehensive Cancer, David Geffen School of Medicine, University of California, Los Angeles, California 90095-1747, USA.
Purpose: Rituximab [chimeric anti-CD20 monoclonal antibody], alone or combined with chemotherapy, is used in the treatment of non-Hodgkin's lymphoma (NHL). Rituximab binds to CD20 and inhibits intracellular survival/growth pathways leading to chemo/immunosensitization of tumor cells in vitro. The contribution of rituximab Fc-FcR interaction in signaling is not known.
View Article and Find Full Text PDF[Three-step purification of preparative-scale antiCD20 (Fab')2].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
October 2008
State Key Laboratory of Experimental Hematology, Institute of Hematology, CAMS and PUMC, Tianjin 300020, China.
Objective: To establish a three-step purification method of preparative-scale antiCD20 (Fab')2 using AKTA prime.
Methods: AntiCD20 (Fab')2 was extracted by hyperosmotic solution and then purified by CM sepharose FF, phenyl sepharose FF, and protein G sepharose FF.
Results: Around 8 mg anti-CD20 (Fab')2, whose purification was 96.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!